0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Verona Pharma Plc Ord 0.1P Share Price Today
58.50
Change
0.00 (0.00%)
Bid
57.00
Ask
60.00

Spread
3.00 (5.263%)
Close
58.50
Open
58.50
High
58.50
58.50
Low
Current Price
58.50
Last Updated: 16:56:50

More about Verona Pharma Plc Ord 0.1P

Verona Pharma Plc Ord 5P is listed on the London Stock Exchange trading with ticker code VRP.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £6,162m, with approximately 105m shares in issue. Over the last year, Verona Pharma Plc Ord 0.1P share price has been traded in a range of 106, hitting a high of 155.00, and a low of 49.00.

Verona Pharma Plc Ord 0.1P, officially known as Verona Pharma Plc Ord 5P was formed in February of 2005, making the company fourteen years old. The company filed its latest accounts on 31st December 2014. Verona Pharma Plc Ord 0.1P currently has 6 directors, and has had 9 previous directors over the last 14 years. In the last set of accounts produced by Uhy Hacker Young, the company showed 284 thousand paid in salaries to the 11 staff (average wage of 26 thousand), with the directors receiving an average 125 thousand each. In the accounts filed in 2014, the company paid 0 in dividends. These accounts also showed Verona Pharma Plc Ord 0.1P to have a net worth of 10.75 million, with 9.97 million held in cash.


Verona Pharma Plc Ord 0.1P is in the Medicine and Biotech Research sector.

Verona Pharma Plc Ord 0.1P is in the AIM 350 index.

What if I invested £1,000 in Verona Pharma Plc Ord 0.1P?
1 month ago 1 year ago
VRP.L£20,172.41 £36,000.00

Verona Pharma Plc Ord 0.1P Share Information

Volume 169.00
Currency GBX
Shares in Issue 105m
Market Capitalisation £6,162m
52 Week High 155.00
52 Week Low 49.00

Compare Verona Pharma Plc Ord 0.1P

Compare Verona Pharma Plc Ord 0.1P with:
Nobody has posted any Verona Pharma Plc Ord 0.1P share chat yet, click here to add one.
Nobody has posted any Verona Pharma Plc Ord 0.1P insights yet, click here to add one.